> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Safety Alert on Perrigo Albuterol Inhalers
- URL: https://www.fdaweb.com/safety-alert-on-perrigo-albuterol-inhalers/
- Published: 2020-09-22T12:00:00.000Z
- Updated: 2026-09-14T16:29:33.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147703

FDA is alerting health care professionals and patients to a recall of all unexpired albuterol sulfate inhalation aerosol manufactured by Catalent Pharma Solutions for Perrigo Pharmaceutical Co. due to possible clogging of the inhaler resulting in patients not receiving enough or any medicine. The albuterol inhalers are used to treat asthma and other conditions, such as chronic obstructive pulmonary disease. “Patients could face health risks if their rescue albuterol inhaler malfunctions and does not relieve symptoms in an emergency situation,” the [safety alert](https://www.fda.gov/drugs/drug-safety-and-availability/fda-alerts-perrigos-voluntary-albuterol-inhaler-recall?utm%5Fmedium=email&utm%5Fsource=govdelivery) says.